I realized in the 2000s and the early 2010s that all the Innovation that I had wanted to do in biomedicine was blocked by the FDA and genomics wasn't simply a technical problem it wasn't simply a logistical problem it was a regulatory problem which meant it was a political problem which meant it was a sovereignty problem 